Clinical Research Directory
Browse clinical research sites, groups, and studies.
COVID-19 in Rheumatic Inflammatory Diseases Under Immuno-suppressive Drugs
Sponsor: University Hospital, Montpellier
Summary
Accurate knowledge of the humoral immune responses induced by SARS-CoV-2 in patients undergoing immunosuppressive therapy is essential to guide recommendations for infected patients and for vaccination policy for uninfected immunosuppressed patients.
Official title: Seroprevalence and Clinical Expression of SARS-CoV-2 Infection in Patients With Chronic Inflammatory Rheumatisms and Impact of Immuno-suppressive Drugs on the Persistence of Anti-SARS-CoV2 Antibodies During Two Years of Follow-up
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
163
Start Date
2021-03-05
Completion Date
2024-02-15
Last Updated
2026-06-12
Healthy Volunteers
No
Conditions
Interventions
Biological samples
Serum and plasma samples. At baseline, 6, 12 and 24 months
Locations (1)
Centre hopsitalier universitaire de Montpellier
Montpellier, Occitanie, France